Search
for
Sort by
Research 211–240 of 814
- Understanding Polycystic Ovary Syndrome
- Dissolving microneedles: an advanced approach for transdermal drug delivery
- The skin and obesity
- Polycystic ovary syndrome: Pathophysiology, Symptoms, Risk factors, and Pharmacological treatment
- Pharmacology of Glycyrrhiza glabra (Mulhatti): The grandfather of herbs
- 104 Flibanserin Subset Analyses and the Androgenics of Hypoactive Sexual Desire Disorder
- The abnormal skin structure of newly born Wistar rat maternally-treated with aspartame: histological and immunohistochemical study
- Effect of neurosteroid dehydroepiandrosterone on the higher nervous activity of old non-human primates
- Reporting on Adverse Clinical Events
- The in vitro plasticity of hair follicle dermal and mesenchymal stem cells
- Abstracts from the Symposium on the Pathophysiology of Hair Growth Organized by the Institute of Dermatology at the Royal Society of Medicine, 29 October 1987
- Drug Reactions Affecting Hair: Diagnosis
- Long COVID syndrome: An unfolding enigma
- Secondary amenorrhea
- Hair Changes due to Drugs
- Stem Cells Therapies in Basic Science and Translational Medicine: Current Status and Treatment Monitoring Strategies
- Clinical features, therapeutic outcomes and recovery period of long COVID
- Adverse Dermatologic Effects of Cardiovascular Drug Therapy: Part III
- REPORTS: Summary of the Recommendations on Sexual Dysfunctions in Women
- Hair Loss in Women
- Tissue Engineering and Regenerative Medicine: Achievements, Future, and Sustainability in Asia
- Biology of the wool follicle: an excursion into a unique tissue interaction system waiting to be re‐discovered
- Physiologic functions of PP2A: Lessons from genetically modified mice
- Current evaluation of amenorrhea
- Safety of dermatologic medications in pregnancy and lactation
- Tumour regression predicts higher risk of sentinel node involvement in thin cutaneous melanomas
- Glutamine Metabolism Controls Stem Cell Fate Reversibility and Long-Term Maintenance in the Hair Follicle
- Fluoroquinolone-induced serious, persistent, multisymptom adverse effects
- Non polycystic ovary syndrome–related endocrine disorders associated with hirsutism
- Current evaluation of amenorrhea